• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西囊性纤维化青少年的抑郁和焦虑:患病率、随时间的稳定性以及与治疗依从性的关系。

Depression and anxiety in adolescents with cystic fibrosis in Brazil: prevalence, stability over time, and relationship with treatment adherence.

作者信息

Rozov Tatiana, Silva Marcos Tadeu Nolasco da, Ribeiro Maria Ângela Gonçalves Oliveira, Damaceno Neiva, Santana Maria Angelica Pinheiro Santos, Marostica Paulo Jose Cauduro, Melotti Roberta de Cássia Nunes Cruz, Martins Valeria de Carvalho, Riedi Carlos Antônio, Souza Edna Lucia Santos de, Ludwig Neto Norberto, Athanazio Rodrigo Abensur, Yamamoto Francyelly Wisnievski, Costa Lusmaia Damaceno Camargo, Chiba Sonia Mayumi, Sad Izabela, Ribeiro José Dirceu, Quittner Alexandra L

机构信息

. Universidade de São Paulo, São Paulo (SP) Brasil.

. Universidade Estadual de Campinas, Campinas (SP) Brasil.

出版信息

J Bras Pneumol. 2025 Jun 13;51(2):e20240416. doi: 10.36416/1806-3756/e20240416. eCollection 2025.

DOI:10.36416/1806-3756/e20240416
PMID:40531733
Abstract

OBJECTIVE

Depression and anxiety have been documented in people with cystic fibrosis (CF), jeopardizing treatment adherence. To date, no studies have assessed the prevalence of psychosocial issues in adolescents with CF in Brazil. We sought to assess the prevalence of depression and anxiety in adolescents with CF in Brazil, as well as the impact of depression and anxiety on treatment adherence.

METHODS

This was a multicenter, prospective, observational, longitudinal study conducted between 2017 and 2019 at 14 CF referral centers in Brazil. We used standardized tools such as the nine-item Patient Health Questionnaire (for depression), the seven-item Generalized Anxiety Disorder scale (for anxiety), and the eight-item Morisky Medication Adherence Scale (for treatment adherence) in order to collect data on 218 CF patients at two different time points.

RESULTS

The prevalence of depression was 19.1% at time point 1 and 15.4% at time point 2. The prevalence of anxiety was 19.1% at time point 1 and 18.0% at time point 2. Depression and anxiety were significantly higher in female patients and lower in those who underwent home physiotherapy or had psychological support. Significant correlations were found between depression and anxiety at both time points, the associations being strongest at time point 1 (r = 0.68; p < 0.001). Most (66.7%) of the study participants reported low adherence to treatment, and the remainder reported either average adherence (in 28%) or high adherence (in 5.3%). Depression and anxiety showed inverse correlations with treatment adherence.

CONCLUSIONS

The prevalence of depression and anxiety in adolescents with CF in Brazil appears to be similar to that reported in other countries, being higher in females and lower in those undergoing home physiotherapy or receiving psychological care. Depression and anxiety appear to correlate with lower treatment adherence. Treating psychosocial issues may effectively improve rates of treatment adherence in adolescents with CF.

摘要

目的

囊性纤维化(CF)患者中存在抑郁和焦虑现象,这会影响治疗依从性。迄今为止,尚无研究评估巴西CF青少年患者心理社会问题的患病率。我们旨在评估巴西CF青少年患者中抑郁和焦虑的患病率,以及抑郁和焦虑对治疗依从性的影响。

方法

这是一项多中心、前瞻性、观察性纵向研究,于2017年至2019年在巴西的14个CF转诊中心进行。我们使用标准化工具,如九项患者健康问卷(用于评估抑郁)、七项广泛性焦虑障碍量表(用于评估焦虑)和八项Morisky药物依从性量表(用于评估治疗依从性),以便在两个不同时间点收集218名CF患者的数据。

结果

在时间点1,抑郁患病率为19.1%,在时间点2为15.4%。在时间点1,焦虑患病率为19.1%,在时间点2为18.0%。女性患者的抑郁和焦虑患病率显著更高,而接受家庭物理治疗或获得心理支持的患者患病率较低。在两个时间点,抑郁和焦虑之间均存在显著相关性,在时间点1相关性最强(r = 0.68;p < 0.001)。大多数(66.7%)研究参与者报告治疗依从性低,其余参与者报告依从性一般(28%)或依从性高(5.3%)。抑郁和焦虑与治疗依从性呈负相关。

结论

巴西CF青少年患者中抑郁和焦虑的患病率似乎与其他国家报告的相似,女性患病率更高,接受家庭物理治疗或接受心理护理的患者患病率较低。抑郁和焦虑似乎与较低的治疗依从性相关。治疗心理社会问题可能有效提高CF青少年患者的治疗依从率。

相似文献

1
Depression and anxiety in adolescents with cystic fibrosis in Brazil: prevalence, stability over time, and relationship with treatment adherence.巴西囊性纤维化青少年的抑郁和焦虑:患病率、随时间的稳定性以及与治疗依从性的关系。
J Bras Pneumol. 2025 Jun 13;51(2):e20240416. doi: 10.36416/1806-3756/e20240416. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.改善囊性纤维化患者气道清除治疗和运动依从性的干预措施。
Cochrane Database Syst Rev. 2023 Jul 18;7(7):CD013610. doi: 10.1002/14651858.CD013610.pub2.
4
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD009530. doi: 10.1002/14651858.CD009530.pub5.
5
Investigation and analysis of mental health status of the older adult in western rural areas.西部农村地区老年人心理健康状况的调查与分析
Front Public Health. 2025 Jul 16;13:1612600. doi: 10.3389/fpubh.2025.1612600. eCollection 2025.
6
Pharmacological interventions for those who have sexually offended or are at risk of offending.针对有性犯罪行为或有性犯罪风险者的药物干预措施。
Cochrane Database Syst Rev. 2015 Feb 18;2015(2):CD007989. doi: 10.1002/14651858.CD007989.pub2.
7
E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions.针对患有长期身体疾病的儿童和青少年焦虑与抑郁的电子健康干预措施。
Cochrane Database Syst Rev. 2018 Aug 15;8(8):CD012489. doi: 10.1002/14651858.CD012489.pub2.
8
Psychological interventions for asthma in children and adolescents.儿童和青少年哮喘的心理干预。
Cochrane Database Syst Rev. 2024 Jan 11;1(1):CD013420. doi: 10.1002/14651858.CD013420.pub2.
9
Psychological therapies for the management of chronic and recurrent pain in children and adolescents.用于治疗儿童和青少年慢性复发性疼痛的心理疗法。
Cochrane Database Syst Rev. 2018 Sep 29;9(9):CD003968. doi: 10.1002/14651858.CD003968.pub5.
10
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.

引用本文的文献

1
Comprehensive care in cystic fibrosis: mental health assessments.囊性纤维化的综合护理:心理健康评估
J Bras Pneumol. 2025 Jun 13;51(2):e20250143. doi: 10.36416/1806-3756/e20250143.

本文引用的文献

1
Heterogeneity in Reported Side Effects Following Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Experiences at a Quaternary CF Care Center.艾力沙卡托-替扎卡托-依伐卡托起始治疗后报告的副作用的异质性:一家四级囊性纤维化护理中心的经验。
Pediatr Pulmonol. 2025 Jan;60(1):e27382. doi: 10.1002/ppul.27382. Epub 2024 Nov 6.
2
Questions and Answers? Depression Symptoms Associated with Elexacaftor/Tezacaftor/Ivacaftor Treatment for Cystic Fibrosis.问答:与依列卡福妥/替扎卡福妥/依伐卡福妥治疗囊性纤维化相关的抑郁症状
Am J Respir Crit Care Med. 2024 Feb 1;209(3):239-241. doi: 10.1164/rccm.202311-2159ED.
3
Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor: Multidimensional Assessment of Neuropsychological Side Effects and Physical and Mental Health Outcomes in Adolescents and Adults.
依伐卡托/泰比卡托/艾氟卡托的纵向影响:青少年和成年人神经心理学副作用及身心健康结果的多维评估。
Chest. 2024 Apr;165(4):800-809. doi: 10.1016/j.chest.2023.10.043. Epub 2023 Nov 3.
4
Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events.依伐卡托/泰他卡托/埃他卡托治疗与抑郁相关事件。
Am J Respir Crit Care Med. 2024 Feb 1;209(3):299-306. doi: 10.1164/rccm.202308-1525OC.
5
Positive and negative impacts of elexacaftor/tezacaftor/ivacaftor: Healthcare providers' observations across US centers.依利卓卡福特/替扎卡福特/依伐卡福特的正反两面影响:美国各中心医疗服务提供者的观察。
Pediatr Pulmonol. 2023 Sep;58(9):2469-2477. doi: 10.1002/ppul.26527. Epub 2023 Jun 2.
6
Pilot of a therapist-guided digital mental health intervention (eHealth CF-CBT) for adults with cystic fibrosis.成人囊性纤维化患者的治疗师指导数字心理健康干预(电子健康 CF-CBT)的飞行员。
Pediatr Pulmonol. 2023 Jul;58(7):2094-2103. doi: 10.1002/ppul.26438. Epub 2023 May 5.
7
Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor.依伐卡托与泰它卡托和艾乐卡托联合治疗成人的神经精神症状管理。
Pediatr Pulmonol. 2023 Jul;58(7):1920-1930. doi: 10.1002/ppul.26412. Epub 2023 Apr 10.
8
A survey assessing the impact of COVID-19 and elexacaftor/tezacaftor/ifavacaftor on both physical and mental health in adults with cystic fibrosis.一项评估 COVID-19 和 elexacaftor/tezacaftor/ifavacaftor 对成年囊性纤维化患者身心健康影响的调查。
Pediatr Pulmonol. 2023 Mar;58(3):662-664. doi: 10.1002/ppul.26260. Epub 2022 Dec 16.
9
Mental health screening in Cystic Fibrosis as an intervention: Patient and caregiver feedback on improving these processes.囊性纤维化中的心理健康筛查作为一种干预措施:患者及照料者对改进这些流程的反馈
Respir Med. 2022 Oct;202:106955. doi: 10.1016/j.rmed.2022.106955. Epub 2022 Aug 27.
10
Feasibility and acceptability of a CF-specific cognitive-behavioral preventive intervention for adults integrated into team-based care.将 CF 特异性认知行为预防干预措施融入团队为基础的照护中对成人的可行性和可接受性。
Pediatr Pulmonol. 2022 Nov;57(11):2781-2790. doi: 10.1002/ppul.26101. Epub 2022 Aug 17.